Prevalence and Screening of Abdominal Aortic Aneurysms Among Men With Coronary Artery Disease (CAD-AAA)

This study has been completed.

Sponsor:

Collaborators:

Kuopio University Hospital

Tampere University Hospital

Information provided by (Responsible Party):

Ville Vänni, North Karelia Central Hospital

ClinicalTrials.gov Identifier:

NCT01897623

First received: July 9, 2013

Last updated: December 15, 2014

Last verified: December 2014

History of Changes

Purpose

The purpose of this study is to investigate the prevalence of abdominal aortic aneurysms (AAA) among male patients with coronary artery disease (CAD) verified in coronary angiography. Ethiology of AAA is known to be common with atherosclerotic arterial diseases (coronary artery disease, peripheral artery disease and carotid artery disease), so the hypothesis is that AAA should be more common among these CAD patients, thus making screening of these patients (for AAA) more cost-efficient.

Study will be carried out as a multi-center prospective screening study. Data will be collected in North Karelia Central Hospital, Kuopio University Hospital and Tampere University Hospital. Data consists of 200 consecutive coronary angiography patients in each hospital, resulting in 600 patients in total. All male patients with diagnosed CAD will be recruited for the study and screened for AAA with ultrasound. Nevertheless, patients with previously known AAA will be excluded from the study.

Condition	Intervention
Abdominal Aortic Aneurysm	Other: ultrasound of aorta


Study Type:	Interventional
Study Design:	Primary Purpose: Screening
Official Title:	Prevalence and Screening of Abdominal Aortic Aneurysms Among Men With Coronary Artery Disease

Resource links provided by NLM:

MedlinePlus related topics: Aneurysms Aortic Aneurysm Coronary Artery Disease Ultrasound

Genetic and Rare Diseases Information Center resources: Abdominal Aortic Aneurysm

U.S. FDA Resources

Further study details as provided by Ville Vänni, North Karelia Central Hospital:

Primary Outcome Measures:

Maximum diameter (mm) of abdominal aorta (outer-to-outer wall) in ultrasound [ Time Frame: upon screening ]


Study Start Date:	July 2013
Study Completion Date:	October 2014
Primary Completion Date:	October 2014 (Final data collection date for primary outcome measure)

Arms	Assigned Interventions
ultrasound of aorta	Other: ultrasound of aorta

Eligibility


Ages Eligible for Study:	Child, Adult, Senior
Sexes Eligible for Study:	Male

Criteria

Inclusion Criteria:

Male patients with coronary artery disease

Exclusion Criteria:

Patient's denial to participate
Female Gender
Already diagnosed or treated abdominal aortic aneurysm

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01897623

Locations


Finland
North Carelia Central Hospital
Joensuu, Pohjois-Karjala, Finland, 80200

Sponsors and Collaborators

North Karelia Central Hospital

Kuopio University Hospital

Tampere University Hospital

More Information


Responsible Party:	Ville Vänni, General surgeon, North Karelia Central Hospital
ClinicalTrials.gov Identifier:	NCT01897623 History of Changes
Other Study ID Numbers:	AAA-CAD-02
Study First Received:	July 9, 2013
Last Updated:	December 15, 2014

Additional relevant MeSH terms:


Coronary Artery Disease Myocardial Ischemia Coronary Disease Aneurysm Aortic Aneurysm Aortic Aneurysm, Abdominal	Heart Diseases Cardiovascular Diseases Arteriosclerosis Arterial Occlusive Diseases Vascular Diseases Aortic Diseases

ClinicalTrials.gov processed this record on June 23, 2017

To Top